MDCAT Biology MCQ #1184

A company is producing a recombinant vaccine. What is the primary advantage of using a recombinant vaccine over a traditional vaccine?

MDCAT Biology MCQ #1184

  1. Question 1

    Q1. A company is producing a recombinant vaccine. What is the primary advantage of using a recombinant vaccine over a traditional vaccine?

    • A) Increased immunogenicity
    • B) Reduced production cost
    • C) Improved safety
    • D) Broader antigenic coverage

    Answer: Improved safety

    Explanation: Recombinant vaccines are safer as they contain specific antigens; traditional vaccines may contain inactivated pathogens.